XNAS · Laboratory Analytical Instruments · S&P 500
$2.10
+$0.14 (+7.14%) today
Open $1.96 High $2.14 Low $1.92 Vol 27K Avg $2.04
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| LMRI | Lumexa Imaging Holdings, Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| AMS | American Shared Hospital Services | XASE | USD | SERVICES-MEDICAL LABORATORIES |
| SERA | Sera Prognostics, Inc. Class A Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| CSTL | Castle Biosciences, Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| ACON | Aclarion, Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| XGN | Exagen Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
52-week price range
Price is 34.6% above its 52-week low and 46.8% below its 52-week high. Trading in the lower half of its annual range — closer to the floor than the ceiling.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.